APO Research
Talk to an analyst

APO RESEARCH · REPORT

Urokinase Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Urokinase Injection Industry Growth and Trends Forecast to 2032

19 December 202592 pages

Choose your research edition.

Industry ResearchUrokinase Injection Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Urokinase Injection Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Urokinase Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Urokinase Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Urokinase Injection Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Urokinase Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Urokinase Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Urokinase Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Urokinase Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Urokinase Injection include NDPHARM, Microbic Biosystems Inc, Techpool, Jiangsu Aidea Pharmaceutical, Jiangxi Haoran Bio-Pharma, LIVZON and Wanhua Biochem, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Urokinase Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Urokinase Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Urokinase Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Urokinase Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Urokinase Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Urokinase Injection Market by Company

NDPHARM

Microbic Biosystems Inc

Techpool

Jiangsu Aidea Pharmaceutical

Jiangxi Haoran Bio-Pharma

LIVZON

Wanhua Biochem

Urokinase Injection Segment by Type

10000-100000IU

100000-1000000IU

Others

Urokinase Injection Segment by Application

Hospital

Clinic

Others

Urokinase Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urokinase Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Urokinase Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urokinase Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Urokinase Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Urokinase Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10000-100000IU Table 2. Major Company of 100000-1000000IU Table 3. Major Company of Others Table 4. Global Urokinase Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Urokinase Injection Sales by Type (2021-2026) & (K Units) Table 6. Global Urokinase Injection Sales Market Share in Volume by Type (2021-2026) Table 7. Global Urokinase Injection Sales by Type (2021-2026) & (US$ Million) Table 8. Global Urokinase Injection Sales Market Share in Value by Type (2021-2026) Table 9. Global Urokinase Injection Price by Type (2021-2026) & (US$/Unit) Table 10. Global Urokinase Injection Sales by Type (2027-2032) & (K Units) Table 11. Global Urokinase Injection Sales Market Share in Volume by Type (2027-2032) Table 12. Global Urokinase Injection Sales by Type (2027-2032) & (US$ Million) Table 13. Global Urokinase Injection Sales Market Share in Value by Type (2027-2032) Table 14. Global Urokinase Injection Price by Type (2027-2032) & (US$/Unit) Table 15. North America Urokinase Injection Sales by Type (2021-2026) & (K Units) Table 16. North America Urokinase Injection Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Urokinase Injection Sales by Type (2021-2026) & (K Units) Table 18. Europe Urokinase Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Urokinase Injection Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Urokinase Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Urokinase Injection Sales by Type (2021-2026) & (K Units) Table 22. Latin America Urokinase Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Urokinase Injection Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Urokinase Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Urokinase Injection Industry Trends Table 26. Urokinase Injection Industry Drivers Table 27. Urokinase Injection Industry Opportunities and Challenges Table 28. Urokinase Injection Industry Restraints Table 29. Global Urokinase Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Urokinase Injection Revenue Market Share by Company (2021-2026) Table 31. Global Urokinase Injection Sales by Company (2021-2026) & (K Units) Table 32. Global Urokinase Injection Sales Share by Company (2021-2026) Table 33. Global Urokinase Injection Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Urokinase Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Urokinase Injection Major Company Production Sites and Headquarters Table 36. Global Urokinase Injection Company, Product Type & Application Table 37. Global Urokinase Injection Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Urokinase Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Urokinase Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Urokinase Injection Sales by Region (2021-2026) & (K Units) Table 42. Global Urokinase Injection Sales Market Share in Volume by Region (2021-2026) Table 43. Global Urokinase Injection Sales by Region (2021-2026) & (US$ Million) Table 44. Global Urokinase Injection Sales Market Share in Value by Region (2021-2026) Table 45. Global Urokinase Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Urokinase Injection Sales by Region (2027-2032) & (K Units) Table 47. Global Urokinase Injection Sales Market Share in Volume by Region (2027-2032) Table 48. Global Urokinase Injection Sales by Region (2027-2032) & (US$ Million) Table 49. Global Urokinase Injection Sales Market Share in Value by Region (2027-2032) Table 50. Global Urokinase Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Urokinase Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Urokinase Injection Sales by Application (2021-2026) & (K Units) Table 53. Global Urokinase Injection Sales Market Share in Volume by Application (2021-2026) Table 54. Global Urokinase Injection Sales by Application (2021-2026) & (US$ Million) Table 55. Global Urokinase Injection Sales Market Share in Value by Application (2021-2026) Table 56. Global Urokinase Injection Price by Application (2021-2026) & (US$/Unit) Table 57. Global Urokinase Injection Sales by Application (2027-2032) & (K Units) Table 58. Global Urokinase Injection Sales Market Share in Volume by Application (2027-2032) Table 59. Global Urokinase Injection Sales by Application (2027-2032) & (US$ Million) Table 60. Global Urokinase Injection Sales Market Share in Value by Application (2027-2032) Table 61. Global Urokinase Injection Price by Application (2027-2032) & (US$/Unit) Table 62. North America Urokinase Injection Sales by Application (2021-2026) & (K Units) Table 63. North America Urokinase Injection Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Urokinase Injection Sales by Application (2021-2026) & (K Units) Table 65. Europe Urokinase Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Urokinase Injection Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Urokinase Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Urokinase Injection Sales by Application (2021-2026) & (K Units) Table 69. Latin America Urokinase Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Urokinase Injection Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Urokinase Injection Sales by Application (2021-2026) & (US$ Million) Table 72. NDPHARM Company Information Table 73. NDPHARM Business Overview Table 74. NDPHARM Urokinase Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. NDPHARM Urokinase Injection Product Portfolio Table 76. NDPHARM Recent Development Table 77. Microbic Biosystems Inc Company Information Table 78. Microbic Biosystems Inc Business Overview Table 79. Microbic Biosystems Inc Urokinase Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Microbic Biosystems Inc Urokinase Injection Product Portfolio Table 81. Microbic Biosystems Inc Recent Development Table 82. Techpool Company Information Table 83. Techpool Business Overview Table 84. Techpool Urokinase Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Techpool Urokinase Injection Product Portfolio Table 86. Techpool Recent Development Table 87. Jiangsu Aidea Pharmaceutical Company Information Table 88. Jiangsu Aidea Pharmaceutical Business Overview Table 89. Jiangsu Aidea Pharmaceutical Urokinase Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Jiangsu Aidea Pharmaceutical Urokinase Injection Product Portfolio Table 91. Jiangsu Aidea Pharmaceutical Recent Development Table 92. Jiangxi Haoran Bio-Pharma Company Information Table 93. Jiangxi Haoran Bio-Pharma Business Overview Table 94. Jiangxi Haoran Bio-Pharma Urokinase Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Jiangxi Haoran Bio-Pharma Urokinase Injection Product Portfolio Table 96. Jiangxi Haoran Bio-Pharma Recent Development Table 97. LIVZON Company Information Table 98. LIVZON Business Overview Table 99. LIVZON Urokinase Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. LIVZON Urokinase Injection Product Portfolio Table 101. LIVZON Recent Development Table 102. Wanhua Biochem Company Information Table 103. Wanhua Biochem Business Overview Table 104. Wanhua Biochem Urokinase Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Wanhua Biochem Urokinase Injection Product Portfolio Table 106. Wanhua Biochem Recent Development Table 107. North America Urokinase Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 108. North America Urokinase Injection Sales by Country (2021-2026) & (K Units) Table 109. North America Urokinase Injection Sales Market Share by Country (2021-2026) Table 110. North America Urokinase Injection Sales Forecast by Country (2027-2032) & (K Units) Table 111. North America Urokinase Injection Sales Market Share Forecast by Country (2027-2032) Table 112. North America Urokinase Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. North America Urokinase Injection Market Size by Country (2021-2026) & (US$ Million) Table 114. North America Urokinase Injection Market Share by Country (2021-2026) Table 115. North America Urokinase Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. North America Urokinase Injection Market Share Forecast by Country (2027-2032) Table 117. Europe Urokinase Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. Europe Urokinase Injection Sales by Country (2021-2026) & (K Units) Table 119. Europe Urokinase Injection Sales Market Share by Country (2021-2026) Table 120. Europe Urokinase Injection Sales Forecast by Country (2027-2032) & (K Units) Table 121. Europe Urokinase Injection Sales Market Share Forecast by Country (2027-2032) Table 122. Europe Urokinase Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Europe Urokinase Injection Market Size by Country (2021-2026) & (US$ Million) Table 124. Europe Urokinase Injection Market Share by Country (2021-2026) Table 125. Europe Urokinase Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Europe Urokinase Injection Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Urokinase Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Urokinase Injection Sales by Country (2021-2026) & (K Units) Table 129. Asia-Pacific Urokinase Injection Sales Market Share by Country (2021-2026) Table 130. Asia-Pacific Urokinase Injection Sales Forecast by Country (2027-2032) & (K Units) Table 131. Asia-Pacific Urokinase Injection Sales Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Urokinase Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Urokinase Injection Market Size by Country (2021-2026) & (US$ Million) Table 134. Asia-Pacific Urokinase Injection Market Share by Country (2021-2026) Table 135. Asia-Pacific Urokinase Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Asia-Pacific Urokinase Injection Market Share Forecast by Country (2027-2032) Table 137. Latin America Urokinase Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Latin America Urokinase Injection Sales by Country (2021-2026) & (K Units) Table 139. Latin America Urokinase Injection Sales Market Share by Country (2021-2026) Table 140. Latin America Urokinase Injection Sales Forecast by Country (2027-2032) & (K Units) Table 141. Latin America Urokinase Injection Sales Market Share Forecast by Country (2027-2032) Table 142. Latin America Urokinase Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Latin America Urokinase Injection Market Size by Country (2021-2026) & (US$ Million) Table 144. Latin America Urokinase Injection Market Share by Country (2021-2026) Table 145. Latin America Urokinase Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Latin America Urokinase Injection Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Urokinase Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Urokinase Injection Sales by Country (2021-2026) & (K Units) Table 149. Middle East and Africa Urokinase Injection Sales Market Share by Country (2021-2026) Table 150. Middle East and Africa Urokinase Injection Sales Forecast by Country (2027-2032) & (K Units) Table 151. Middle East and Africa Urokinase Injection Sales Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Urokinase Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Urokinase Injection Market Size by Country (2021-2026) & (US$ Million) Table 154. Middle East and Africa Urokinase Injection Market Share by Country (2021-2026) Table 155. Middle East and Africa Urokinase Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Middle East and Africa Urokinase Injection Market Share Forecast by Country (2027-2032) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Urokinase Injection Distributors List Table 160. Urokinase Injection Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Urokinase Injection Image Figure 2. Global Urokinase Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Urokinase Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Urokinase Injection Sales (2021-2032) & (K Units) Figure 5. 10000-100000IU Image Figure 6. Global 10000-100000IU Sales YoY Growth (2021-2032) & (K Units) Figure 7. 100000-1000000IU Image Figure 8. Global 100000-1000000IU Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Urokinase Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Urokinase Injection Market Share by Type 2025 VS 2032 Figure 13. North America Urokinase Injection Sales Market Share in Volume by Type in 2025 Figure 14. North America Urokinase Injection Sales Market Share in Value by Type in 2025 Figure 15. Europe Urokinase Injection Sales Market Share in Volume by Type in 2025 Figure 16. Europe Urokinase Injection Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Urokinase Injection Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Urokinase Injection Sales Market Share in Value by Type in 2025 Figure 19. Latin America Urokinase Injection Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Urokinase Injection Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Urokinase Injection Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Urokinase Injection Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Urokinase Injection Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Urokinase Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Urokinase Injection Market Share by Application 2025 VS 2032 Figure 33. North America Urokinase Injection Sales Market Share in Volume by Application in 2025 Figure 34. North America Urokinase Injection Sales Market Share in Value by Application in 2025 Figure 35. Europe Urokinase Injection Sales Market Share in Volume by Application in 2025 Figure 36. Europe Urokinase Injection Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Urokinase Injection Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Urokinase Injection Sales Market Share in Value by Application in 2025 Figure 39. Latin America Urokinase Injection Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Urokinase Injection Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Urokinase Injection Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Urokinase Injection Sales Market Share in Value by Application in 2025 Figure 43. North America Urokinase Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Urokinase Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Urokinase Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Urokinase Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Urokinase Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Urokinase Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Urokinase Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Urokinase Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Urokinase Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Urokinase Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Urokinase Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Urokinase Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Urokinase Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Urokinase Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Urokinase Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Urokinase Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Urokinase Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Urokinase Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Urokinase Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Urokinase Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Urokinase Injection Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Urokinase Injection Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 10000-100000IU
  • 100000-1000000IU
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • NDPHARM
  • Microbic Biosystems Inc
  • Techpool
  • Jiangsu Aidea Pharmaceutical
  • Jiangxi Haoran Bio-Pharma
  • LIVZON
  • Wanhua Biochem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Urokinase Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Urokinase Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Urokinase Injection Market by Type
  6. 1.3.1 10000-100000IU
  7. 1.3.2 100000-1000000IU
  8. 1.3.3 Others
  9. 1.4 Global Urokinase Injection Market Size by Type
  10. 1.4.1 Global Urokinase Injection Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Urokinase Injection Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Urokinase Injection Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Urokinase Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Urokinase Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Urokinase Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Urokinase Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Urokinase Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Urokinase Injection Industry Trends
  2. 2.2 Urokinase Injection Industry Drivers
  3. 2.3 Urokinase Injection Industry Opportunities and Challenges
  4. 2.4 Urokinase Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Urokinase Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Urokinase Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Urokinase Injection Price (2021-2026)
  4. 3.4 Global Urokinase Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Urokinase Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Urokinase Injection Company, Product Type & Application
  7. 3.7 Global Urokinase Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Urokinase Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Urokinase Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Urokinase Injection Tier 1, Tier 2, and Tier 3
4 Urokinase Injection Regional Status and Outlook
  1. 4.1 Global Urokinase Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Urokinase Injection Historic Market Size by Region
  3. 4.2.1 Global Urokinase Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Urokinase Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Urokinase Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Urokinase Injection Forecasted Market Size by Region
  7. 4.3.1 Global Urokinase Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Urokinase Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Urokinase Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Urokinase Injection by Application
  1. 5.1 Urokinase Injection Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Urokinase Injection Market Size by Application
  6. 5.2.1 Global Urokinase Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Urokinase Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Urokinase Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Urokinase Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Urokinase Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Urokinase Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Urokinase Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Urokinase Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 NDPHARM
  2. 6.1.1 NDPHARM Company Information
  3. 6.1.2 NDPHARM Business Overview
  4. 6.1.3 NDPHARM Urokinase Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 NDPHARM Urokinase Injection Product Portfolio
  6. 6.1.5 NDPHARM Recent Developments
  7. 6.2 Microbic Biosystems Inc
  8. 6.2.1 Microbic Biosystems Inc Company Information
  9. 6.2.2 Microbic Biosystems Inc Business Overview
  10. 6.2.3 Microbic Biosystems Inc Urokinase Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Microbic Biosystems Inc Urokinase Injection Product Portfolio
  12. 6.2.5 Microbic Biosystems Inc Recent Developments
  13. 6.3 Techpool
  14. 6.3.1 Techpool Company Information
  15. 6.3.2 Techpool Business Overview
  16. 6.3.3 Techpool Urokinase Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Techpool Urokinase Injection Product Portfolio
  18. 6.3.5 Techpool Recent Developments
  19. 6.4 Jiangsu Aidea Pharmaceutical
  20. 6.4.1 Jiangsu Aidea Pharmaceutical Company Information
  21. 6.4.2 Jiangsu Aidea Pharmaceutical Business Overview
  22. 6.4.3 Jiangsu Aidea Pharmaceutical Urokinase Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Jiangsu Aidea Pharmaceutical Urokinase Injection Product Portfolio
  24. 6.4.5 Jiangsu Aidea Pharmaceutical Recent Developments
  25. 6.5 Jiangxi Haoran Bio-Pharma
  26. 6.5.1 Jiangxi Haoran Bio-Pharma Company Information
  27. 6.5.2 Jiangxi Haoran Bio-Pharma Business Overview
  28. 6.5.3 Jiangxi Haoran Bio-Pharma Urokinase Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Jiangxi Haoran Bio-Pharma Urokinase Injection Product Portfolio
  30. 6.5.5 Jiangxi Haoran Bio-Pharma Recent Developments
  31. 6.6 LIVZON
  32. 6.6.1 LIVZON Company Information
  33. 6.6.2 LIVZON Business Overview
  34. 6.6.3 LIVZON Urokinase Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 LIVZON Urokinase Injection Product Portfolio
  36. 6.6.5 LIVZON Recent Developments
  37. 6.7 Wanhua Biochem
  38. 6.7.1 Wanhua Biochem Company Information
  39. 6.7.2 Wanhua Biochem Business Overview
  40. 6.7.3 Wanhua Biochem Urokinase Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Wanhua Biochem Urokinase Injection Product Portfolio
  42. 6.7.5 Wanhua Biochem Recent Developments
7 North America by Country
  1. 7.1 North America Urokinase Injection Sales by Country
  2. 7.1.1 North America Urokinase Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Urokinase Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Urokinase Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Urokinase Injection Market Size by Country
  6. 7.2.1 North America Urokinase Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Urokinase Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Urokinase Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Urokinase Injection Sales by Country
  2. 8.1.1 Europe Urokinase Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Urokinase Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Urokinase Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Urokinase Injection Market Size by Country
  6. 8.2.1 Europe Urokinase Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Urokinase Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Urokinase Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Urokinase Injection Sales by Country
  2. 9.1.1 Asia-Pacific Urokinase Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Urokinase Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Urokinase Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Urokinase Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Urokinase Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Urokinase Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Urokinase Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Urokinase Injection Sales by Country
  2. 10.1.1 South America Urokinase Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Urokinase Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Urokinase Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Urokinase Injection Market Size by Country
  6. 10.2.1 South America Urokinase Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Urokinase Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Urokinase Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Urokinase Injection Sales by Country
  2. 11.1.1 Middle East and Africa Urokinase Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Urokinase Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Urokinase Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Urokinase Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Urokinase Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Urokinase Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Urokinase Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Urokinase Injection Value Chain Analysis
  2. 12.1.1 Urokinase Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Urokinase Injection Production Mode & Process
  7. 12.2 Urokinase Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Urokinase Injection Distributors
  10. 12.2.3 Urokinase Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst